Last checked at 20 May 2021 13:35
Ap19
FORM 8.3 - Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 18 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,655,818 | 1.28% | 172,212 | 0.13% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 0 | 0.00% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,734,277 | 1.34% | 178,312 | 0.14% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 266.3300 USD |
Purchase | 1 | 264.0200 USD |
Purchase | 80 | 267.3200 USD |
Purchase | 100 | 267.2400 USD |
Purchase | 100 | 264.2200 USD |
Purchase | 104 | 266.9880 USD |
Purchase | 231 | 265.1755 USD |
Purchase | 248 | 267.7300 USD |
Purchase | 400 | 264.1450 USD |
Purchase | 476 | 263.6700 USD |
Purchase | 518 | 265.3950 USD |
Purchase | 600 | 264.0941 USD |
Purchase | 937 | 264.0546 USD |
Purchase | 1,319 | 264.3748 USD |
Purchase | 1,406 | 263.6732 USD |
Purchase | 1,780 | 266.2159 USD |
Purchase | 2,037 | 264.0921 USD |
Purchase | 2,068 | 267.0854 USD |
Purchase | 2,458 | 265.8989 USD |
Purchase | 2,679 | 266.5237 USD |
Purchase | 2,980 | 263.6726 USD |
Purchase | 3,126 | 264.3861 USD |
Purchase | 3,196 | 266.3756 USD |
Purchase | 4,595 | 267.0474 USD |
Purchase | 12,236 | 266.2871 USD |
Purchase | 12,633 | 264.3340 USD |
Purchase | 47,536 | 266.8931 USD |
Sale | 1 | 266.3300 USD |
Sale | 1 | 267.1600 USD |
Sale | 1 | 267.0100 USD |
Sale | 1 | 266.5400 USD |
Sale | 2 | 267.6500 USD |
Sale | 17 | 267.0900 USD |
Sale | 59 | 267.0506 USD |
Sale | 85 | 267.0600 USD |
Sale | 100 | 264.2200 USD |
Sale | 100 | 265.5240 USD |
Sale | 100 | 266.6700 USD |
Sale | 100 | 266.9800 USD |
Sale | 100 | 266.9900 USD |
Sale | 100 | 267.2100 USD |
Sale | 100 | 267.9400 USD |
Sale | 100 | 268.1900 USD |
Sale | 152 | 266.4007 USD |
Sale | 165 | 266.9000 USD |
Sale | 200 | 267.0150 USD |
Sale | 200 | 265.3750 USD |
Sale | 245 | 266.6166 USD |
Sale | 272 | 267.0257 USD |
Sale | 286 | 266.4767 USD |
Sale | 300 | 265.8466 USD |
Sale | 301 | 267.5095 USD |
Sale | 396 | 266.8227 USD |
Sale | 400 | 266.4090 USD |
Sale | 400 | 266.5000 USD |
Sale | 500 | 264.0690 USD |
Sale | 1,052 | 266.6726 USD |
Sale | 1,061 | 266.5752 USD |
Sale | 1,407 | 263.6734 USD |
Sale | 1,444 | 267.0759 USD |
Sale | 1,618 | 266.4900 USD |
Sale | 1,758 | 265.7810 USD |
Sale | 1,858 | 263.6718 USD |
Sale | 2,633 | 267.0890 USD |
Sale | 2,722 | 266.4493 USD |
Sale | 3,673 | 263.6700 USD |
Sale | 4,019 | 267.0042 USD |
Sale | 4,074 | 264.0921 USD |
Sale | 4,196 | 266.0480 USD |
Sale | 4,725 | 265.8693 USD |
Sale | 6,614 | 265.9435 USD |
Sale | 7,505 | 266.9606 USD |
Sale | 9,792 | 263.9634 USD |
Sale | 12,296 | 267.0175 USD |
Sale | 26,310 | 266.8060 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 20 May 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005628/en/
Copyright Business Wire 2021